New Insights on Intrahepatic Cholestasis of Pregnancy

Clinics in Liver Disease

Volumn 20, Issue 1, 2016, Pages 177-189

  Floreani, Annarosa ^a   Gervasi, Maria Teresa ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Bile salts; Cholelithiasis; Intrahepatic cholestasis of pregnancy; Itching; Ursodeoxycholic acid

Indexed keywords

PLACEBO; RIFAMPICIN; URSODEOXYCHOLIC ACID; BILE ACID; CHOLAGOGUE;

BIOCHEMISTRY; BLOOD LEVEL; CLINICAL EFFECTIVENESS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG EFFICACY; DRUG RESPONSE; FETUS OUTCOME; GENETIC VARIABILITY; HUMAN; INTRAHEPATIC CHOLESTASIS; MATERNAL OUTCOME; MOLECULAR PATHOLOGY; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PREGNANCY; REVIEW; RISK ASSESSMENT; RISK FACTOR; BLOOD; CHOLESTASIS, INTRAHEPATIC; FEMALE; GENETICS; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

BILE ACIDS AND SALTS; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS, INTRAHEPATIC; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS; URSODEOXYCHOLIC ACID;

EID: 84947723569     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2015.08.010     Document Type: Review

References (75)

1. Williamson C., Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol 2014, 124:120-133.
2. Joshi D., James A., Quaglia A., et al. Liver disease in pregnancy. Lancet 2010, 375:594-605.
3. Arrese M., Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann Hepatol 2006, 5:202-205.
4. Qi H.B., Shao Y., Wu W.X., et al. Grading of intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 2004, 39:14-17.
5. Locatelli A., Roncaglia N., Arreghini A., et al. Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy. Br J Obstet Gynaecol 1999, 106:498-500.
6. Paternoster D.M., Fabris F., Palù G., et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand 2002, 81:99-103.
7. Ropponen A., Sund R., Riikonen S., et al. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006, 43:723-728.
8. Marschall H.-U., Shemer E.W., Ludvigsson J.F., et al. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population based cohort study. Hepatology 2013, 58:1385-1391.
9. Belay T., Woldegiorgis H., Gress T., et al. Intrahepatic cholestasis of pregnancy with concomitant hepatitis C virus infection, Joan C. Edwards SOM, Marshall University. Eur J Gastroenterol Hepatol 2015, 27:372-374.
10. Hinoshita E., Taguchi K., Inokuchi A., et al. Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J Hepatol 2001, 35:765-773.
11. Iwata R., Baur K., Stigier B., et al. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin Sci (Lond) 2011, 120:287-296.
12. Berg B., Helm G., Petersohn L., et al. Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynecol 1996, 175:957-960.
13. Laatikainen T., Ikonen E. Fetal prognosis in obstetric hepatosis. Ann Chir Gynaecol Fenn 1975, 64:155-164.
14. Reis H., Baez M.E., Gonzalez M.C., et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals in Chile. J Hepatol 2000, 32:542-549.
15. Reis H., Kauppila A., Korpela H., et al. Low serum selenium concentration and glutathione peroxidase activity in intrahepatic cholestasis of pregnancy. Br Med J 1987, 294:150-152.
16. Wilkstrom Shemer E., Marshall H.U. Decreased 1,25 dihydroxy vitamin D levels in women with intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand 2010, 89:1420-1423.
17. Gonzales M., Reyes H., Arrese M., et al. Intrahepatic cholestasis of pregnancy in twin pregnancies. J Hepatol 1989, 9:84-90.
18. Rioseco A., Ivankovic M., Manzur A., et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994, 170:890-895.
19. Savander M., Ropponen A., Avela K., et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 2003, 52:1025-1029.
20. Heinonen S., Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999, 94:189-193.
21. Bull L.N., van Eijk M.J., Pawlikowska L., et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998, 20:233-238.
22. Klomp L.W., Vargos J.C., van Mil S.W., et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 2004, 40:27-38.
23. Mullenbach R., Bennet A., Tetlow N., et al. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 2005, 54:829-834.
24. Dixon P.H., Wadsworth A., Chambers J., et al. A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy. Am J Gastroenterol 2014, 109:76-84.
25. Noe J., Stieger B., Meier P.J. Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology 2002, 123:1659-1660.
26. Jacquemin E., Cresteil D., Manouvrier S., et al. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999, 353:210-211.
27. Dixon P.H., Weerasekera N., Linton K.J., et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2009, 9:1209-1217.
28. Floreani A., Carderi I., Paternoster D., et al. Hepatobiliary phospholipid transporter ABCB4, MDR3 variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Dig Liver Dis 2008, 40:366-370.
29. Schneider G., Paus T.C., Kullak-Ublick G.A., et al. Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy. Hepatology 2007, 45:150-158.
30. Sookian S., Castano G., Burguen A., et al. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. J Hepatol 2008, 48:125-132.
31. Kim I., Ahn S.H., Choi M., et al. Differential regulation of the bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 2007, 48:2664-2672.
32. Van Mil S.W., Milona A., Dixon P.H., et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007, 133:507-516.
33. Davit-Spraul A., Gonzales E., Jacquemin E. NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations. Clin Res Hepatol Gastroenterol 2012, 36:569-573.
34. Floreani A., Caroli D., Lazzari R., et al. Intrahepatic cholestasis of pregnancy: new insights into its pathogenesis. J Matern Fetal Neonatal Med 2013, 26:1410-1415.
35. He P., Wang F., Jiang Y., et al. Placental proteome alterations in women with intrahepatic cholestasis of pregnancy. Int J Gynaecol Obstet 2014, 126:256-259.
36. Du Q., Pan Y., Zhang Y., et al. Placental gene-expression profiles of intrahepatic cholestasis of pregnancy reveal involvement of multiple molecular pathways in blood vessel formation and inflammation. BMC Med Genomics 2014, 7:42-52.
37. Brites D., Rodrigues C.M.P., da Concejao Cardos M., et al. Unusual case of severe cholestasis of pregnancy with early onset, improved by ursodeoxycholic acid administration. Eur J Obstet Gynecol Reprod Biol 1998, 76:165-168.
38. Chao T.T., Sheffield J.S. Primary dermatologic findings with early-onset intrahepatic cholestasis of pregnancy. Obstet Gynecol 2011, 117:456-458.
39. Zamah A.M., El-Sayed Y.Y., Milki A.A. Two cases of cholestasis in the first trimester of pregnancy after ovarian hyperstimulation. Fertil Steril 2008, 90:1202.e7-1202.e10.
40. Zhou L., Qi H., Luo X. Analysis of clinical characteristics and perinatal outcome of early-onset intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 2013, 48:20-24.
41. Lehroff S., Pomeranz M.K. Specific dermatoses of pregnancy and their treatment. Dermatol Ther 2013, 26:274-284.
42. Kenyon A.P., Piercy C.N., Girling J., et al. Pruritus may precede abnormal liver function tests in pregnant women with obstetric cholestasis: a longitudinal analysis. BJOG 2001, 108:1190-1192.
43. Walker I.A., Nelson-Piercy C., Williamson C. Role of bile acid measurement in pregnancy. Ann Clin Biochem 2002, 39:105-113.
44. Glantz A., Marschall H.U., Mattson L.A. Intrahepatic cholestasis of pregnancy: relationships observed bile acid levels and fetal complication rates. Hepatology 2004, 40:467-474.
45. German A.M., Kato S., Carvajal J.A., et al. Bile acids increase response and expression of human myometric receptor. Am J Obstet Gynecol 2003, 189:577-582.
46. Israel E.J., Guzman M.L., Campos G.A. Maximal response to oxytocin of the isolated myometrium from pregnant patients with intrahepatic cholestasis. Acta Obstet Gynecol Scand 1986, 65:581-582.
47. Brouwers L., Koster M.P., Page-Christiaens G.C., et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 2015, 212:100.e1-100.e7.
48. Milkiewicz P., Gallagher R., Chambers J., et al. Obstetric cholestasis with elevated gamma glutamyl transpeptidase: incidence, presentation and treatment. J Gastroenterol Hepatol 2003, 18:1283-1286.
49. Jansen P.L.M., Muller M. Genetic cholestasis: lessons from the molecular physiology of bile formation. Can J Gastroenterol 2000, 14:233-238.
50. Kremer A.E., Bolier R., Dixon P.H., et al. Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy. J Hepatol 2015, 62:897-904.
51. Martineau M.G., Raker C., Dixon P.H., et al. The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care 2015, 38:243-248.
52. Reid R., Ivery K.J., Rencoret R.H., et al. Fetal complications of obstetric cholestasis. Br Med J 1976, 1:870-872.
53. Henderson C.E., Shah R.R., Gottimukkala S., et al. Primum non nocere: how active management became modus operandi for intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 2014, 124:189-196.
54. Bannister-Tyrrell M., Ford J.B., Morris J.M., et al. Intrahepatic cholestasis of pregnancy is not associated with stillbirth in an Australian maternity population. Eur J Obstet Gynecol Reprod Biol 2014, 176:203-206.
55. Suri V., Jain R., Aggarwal N., et al. Useful of fetal monitoring in intrahepatic cholestasis of pregnancy: a prospective study. Arch Gynecol Obstet 2012, 286:1419-1424.
56. Lee R.H., Kwok K.M., Ingles S., et al. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am J Perinatol 2008, 25:341-345.
57. Oztekin D., Aydal I., Oztekin O., et al. Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy. Arch Gynecol Obstet 2009, 280:975-979.
58. Rook M., Vargas J., Caughey A., et al. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in Northern California cohort. PLoS One 2012, 7:1-6.
59. Jin J., Pan S., Huang L., et al. Risk factors for adverse fetal outcomes among women with early-versus late-onset intrahepatic cholestasis of pregnancy. Int J Gynaecol Obstet 2015, 128(3):236-240.
60. Hu Y., Ding Y.-L., Yu L. The impact of intrahepatic cholestasis of pregnancy with hepatitis B virus infection on perinatal outcomes. Ther Clin Risk Manag 2014, 10:381-385.
61. Hamalainen S.T., Turunen K., Kosunen E., et al. Men's health is not affected by their mothers' intrahepatic cholestasis of pregnancy. Am J Mens Health 2015, [Epub ahead of print].
62. Lucena J.-F., Herrero J.I., Quiroga G., et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adult biliary cirrhosis. Gastroenterology 2003, 124:1037-1042.
63. Davit-Spraul A., Gonzales E., Baussan C., et al. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis 2010, 30:134-146.
64. Poupon R., Rosmorduc O., Boelle P.Y., et al. Genotype-phenotype relationships in the low-phospholipids-associated cholelithiasis syndrome: a study of 156 consecutive patients. Hepatology 2013, 58:1105-1110.
65. Pasmant E., Goussard P., Baranes L., et al. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis. Eur J Hum Genet 2012, 20:277-282.
66. Wilkstromer Shemer E.A., Stephansson O., Thuresson M., et al. Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study. J Hepatol 2015, 63(2):456-461.
67. Hay J.E. Liver disease in pregnancy. Hepatology 2008, 47:1067-1076.
68. Bacq Y., Sentilhes L., Reyes H.B., et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology 2012, 143:1492-1501.
69. Erlinger S. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: good, but can do better. Clin Res Hepatol Gastroenterol 2013, 37:117-118.
70. Estiù M.C., Monte M.J., Rivas L., et al. Effects of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy. Br J Clin Pharmacol 2014, 79:316-329.
71. Grand'Maison S., Durand M., Mahone M. The effect of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including non-randomized studies. J Obstet Gynaecol Can 2014, 36:632-641.
72. Gurung V., Stokes M., Middleton P., et al. Interventions for treating cholestasis in pregnancy. Cochrane Database Syst Rev 2013, (6). [review], CD000493.
73. Marshall H.U., Wagner M., Zollner G., et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005, 129:476-485.
74. Geenes V., Chambers J., Khurana R., et al. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol 2015, 189:59-63.
75. Puljic A., Kim E., Page J., et al. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age. Am J Obstet Gynecol 2015, 212:667.e1-667.e5.